Correlation Between SAB Biotherapeutics and Biovaxys Technology
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Biovaxys Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Biovaxys Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Biovaxys Technology Corp, you can compare the effects of market volatilities on SAB Biotherapeutics and Biovaxys Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Biovaxys Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Biovaxys Technology.
Diversification Opportunities for SAB Biotherapeutics and Biovaxys Technology
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between SAB and Biovaxys is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Biovaxys Technology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovaxys Technology Corp and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Biovaxys Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovaxys Technology Corp has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Biovaxys Technology go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Biovaxys Technology
Given the investment horizon of 90 days SAB Biotherapeutics is expected to under-perform the Biovaxys Technology. But the stock apears to be less risky and, when comparing its historical volatility, SAB Biotherapeutics is 2.07 times less risky than Biovaxys Technology. The stock trades about -0.05 of its potential returns per unit of risk. The Biovaxys Technology Corp is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 1.47 in Biovaxys Technology Corp on September 1, 2024 and sell it today you would earn a total of 3.56 from holding Biovaxys Technology Corp or generate 242.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.63% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Biovaxys Technology Corp
Performance |
| Timeline |
| SAB Biotherapeutics |
| Biovaxys Technology Corp |
SAB Biotherapeutics and Biovaxys Technology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Biovaxys Technology
The main advantage of trading using opposite SAB Biotherapeutics and Biovaxys Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Biovaxys Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovaxys Technology will offset losses from the drop in Biovaxys Technology's long position.| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
| Biovaxys Technology vs. Rigel Pharmaceuticals | Biovaxys Technology vs. Geron | Biovaxys Technology vs. Verastem | Biovaxys Technology vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |